Ritva Tikkanen
Principal Investigator
Justus-Liebig-Universität Gießen
I'm working on
2 years ago
Precision therapies for rare diseases
About
My group is specialized in developing personalized precision therapies for rare genetic diseases, especially lysosomal storage disorders and neurotransmitter diseases. Our approaches cover gene therapy (AAV), ERT and small molecules.
Partnering listings
Learn more
Justus-Liebig-Universität Gießen
Base editing and gene therapy for xeroderma pigmentosum XPA variants
Innovative base editing and gene therapy solutions targeting XPA gene mutations in xeroderma pigmentosum patients, offering potential treatment for severe photosensitivity and skin cancer risk.
TechnologyConceptualUniversity
Justus-Liebig-Universität Gießen
Base-editing therapy for alpha-galactosidase variants in Fabry disease
Innovative base-editing approaches aim to correct harmful alpha-galactosidase variants D313Y and A143T, implicated in Fabry disease. This solution promises new treatment options for patients excluded from standard therap...
TechnologyConceptualUniversity
Ritva Tikkanen
Principal Investigator
Justus-Liebig-Universität GießenWork experience
Principal Investigator
Top industry applications
Pharmaceuticals and drug delivery
Open to opportunities in
Biochemical EngineeringBiochemistryCell BiologyCell TherapyDrug DeliveryGene Therapy
Last updated Nov 2024
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.